A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study
暂无分享,去创建一个
V. D’Orazi | V. Pasta | G. de Vincentis | G. Follacchio | M. Monti | P. Anibaldi | S. Iacobelli | R. Merola | F. Monteleone
[1] V. D’Orazi,et al. Breast Mondor’s disease: Diagnosis and management of six new cases of this underestimated pathology , 2015, Phlebology.
[2] V. D’Orazi,et al. Primitive sarcoma of the breast: new insight on the proper surgical management , 2015, Journal of experimental & clinical cancer research : CR.
[3] V. D’Orazi,et al. Typical and atypical lymphatic flows in breast carcinoma. , 2015, Annali italiani di chirurgia.
[4] V. D’Orazi,et al. Original technique for preoperative preparation of patients and intraoperative localization of parathyroid adenomas. , 2015, Il Giornale di chirurgia.
[5] Francesco Scopinaro,et al. High-resolution, handheld camera use for occult breast lesion localization plus sentinel node biopsy (SNOLL): a single-institution experience with 186 patients. , 2015, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[6] Kevin A. Henry,et al. Annual Report to the Nation on the Status of Cancer, 1975–2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State , 2015, Journal of the National Cancer Institute.
[7] C. Shriver,et al. Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes , 2014, Journal of experimental & clinical cancer research : CR.
[8] V. D’Orazi,et al. Rare chondrosarcoma of the breast treated with quadrantectomy instead of mastectomy: A case report , 2014, Oncology letters.
[9] V. D’Orazi,et al. HF ultrasound vs PET-CT and telethermography in the diagnosis of In-transit metastases from melanoma: a prospective study and review of the literature , 2014, Journal of experimental & clinical cancer research : CR.
[10] V. D’Orazi,et al. Contralateral axillary metastases from breast cancer. Personal experience and review of literature. , 2014, Annali italiani di chirurgia.
[11] N. Petrelli,et al. Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations. , 2012, Surgical oncology.
[12] Ricardo Bonomi,et al. Comparison of radioguided occult lesion localization (ROLL) and wire localization for non‐palpable breast cancers: A meta‐analysis , 2012, Journal of surgical oncology.
[13] C. Goldsmith,et al. Systematic review of radioguided surgery for non-palpable breast cancer. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[14] R. Rosenfeld,et al. Cases , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[15] A. Luini,et al. Sentinel Lymph Node Biopsy in Breast Cancer: Ten-Year Results of a Randomized Controlled Study , 2010, Annals of surgery.
[16] L. Tafra,et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. , 2009, Journal of the American College of Surgeons.
[17] Michael V Knopp,et al. A comprehensive overview of radioguided surgery using gamma detection probe technology , 2009, World journal of surgical oncology.
[18] B. Bodanese,et al. Radioguided breast surgery for occult lesion localization – correlation between two methods , 2008, Journal of experimental & clinical cancer research : CR.
[19] C. Nos,et al. Simplified Technique of Radioguided Occult Lesion Localization (ROLL) Plus Sentinel Lymph Node Biopsy (SNOLL) in Breast Carcinoma , 2008, Annals of Surgical Oncology.
[20] P. Del Bianco,et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[21] H. Medina-Franco,et al. Radioguided occult lesion localization (ROLL) versus wire‐guided lumpectomy for non‐palpable breast lesions: A randomized prospective evaluation , 2008, Journal of surgical oncology.
[22] D. Nitti,et al. A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer: Results of the Sentinella/GIVOM Trial , 2008, Annals of surgery.
[23] T. Julian,et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. , 2007, The Lancet. Oncology.
[24] A. Luini,et al. Occult Breast Lesion Localization plus Sentinel Node Biopsy (SNOLL): Experience with 959 Patients at the European Institute of Oncology , 2007, Annals of Surgical Oncology.
[25] D. Berry,et al. Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.
[26] Dino Amadori,et al. The global breast cancer burden: variations in epidemiology and survival. , 2005, Clinical breast cancer.
[27] A. Luini,et al. Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[28] Umberto Veronesi,et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.
[29] P. Tanis,et al. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[30] E. Rutgers,et al. Single Intralesional Tracer Dose for Radio-Guided Excision of Clinically Occult Breast Cancer and Sentinel Node , 2001, Annals of Surgical Oncology.
[31] A. Luini,et al. Radiation protection in radioguided surgery of breast cancer. , 1999, Nuclear medicine communications.
[32] R. Foster,et al. The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.
[33] A. Giuliano,et al. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. , 1996, Journal of the American College of Surgeons.
[34] J. G. Schuler,et al. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. , 1996, Archives of surgery.
[35] C. Carter,et al. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.
[36] A. Stagnitti,et al. The impact of presurgical magnetic resonance in early breast cancer: an observational study. , 2012, European journal of gynaecological oncology.
[37] A. Luini,et al. Radioguided surgery of occult breast lesions. , 1998, European journal of cancer.
[38] E. Wouters,et al. Chemical pleurodesis with mitoxantrone in the management of malignant effusions. , 1998, European journal of cancer.
[39] Donald E. Henson,et al. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .